Presepsin:albumin ratio and C-reactive protein:albumin ratio as novel sepsis-based prognostic scores : A retrospective study

OBJECTIVE: To investigate the prognostic value of the presepsin:albumin ratio and C‑reactive protein:albumin ratio in patients with sepsis in the intensive care unit (ICU).

METHODS: A total of 228 (129 males and 99 females) patients with newly diagnosed sepsis were included in the study. The relationship between the C‑reactive protein:albumin ratio, presepsin:albumin ratio, clinicopathologic parameters, and overall survival were investigated. The associations between C‑reactive protein:albumin ratio and presepsin:albumin ratio were evaluated alongside other inflammation-based prognostic scores such as quick Sepsis Related Organ Failure Assessment (qSOFA).

RESULTS: The presepsin:albumin ratio was significantly higher in non-survivors (p < 0.01). Patients with a high presepsin:albumin ratio had worse overall survival compared with patients with high C‑reactive protein:albumin ratio levels (p < 0.001).

CONCLUSION: Presepsin and presepsin:albumin ratio are markers of adverse prognosis in patients with sepsis and are superior to C‑reactive protein and C‑reactive protein:albumin ratio for this purpose. Presepsin:albumin ratio may be a novel marker of poor prognosis in patients with sepsis in intensive care units.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:132

Enthalten in:

Wiener klinische Wochenschrift - 132(2020), 7-8 vom: 14. Apr., Seite 182-187

Sprache:

Englisch

Beteiligte Personen:

Kaplan, Mustafa [VerfasserIn]
Duzenli, Tolga [VerfasserIn]
Tanoglu, Alpaslan [VerfasserIn]
Cakir Guney, Basak [VerfasserIn]
Onal Tastan, Yesim [VerfasserIn]
Bicer, Hatice Selcen [VerfasserIn]

Links:

Volltext

Themen:

9007-41-4
Albumin
Albumins
Biomarkers
C‑reactive protein
C-Reactive Protein
Journal Article
Lipopolysaccharide Receptors
Peptide Fragments
Presepsin
Presepsin protein, human
Sepsis

Anmerkungen:

Date Completed 17.11.2020

Date Revised 17.11.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s00508-020-01618-9

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306548526